Dominion Energy’s V.C. Summer nuclear power plant, in Jenkinsville, S.C., has been authorized to operate for 80 years, until August 2062, following the renewal of its operating license by the Nuclear Regulatory Commission for a second time.

In its June 30 announcement of a new deal to purchase 200 MW from Commonwealth Fusion Systems' (CFS) first ARC fusion power plant planned for Virginia, Google called it “the largest direct corporate offtake agreement for fusion energy” ever. While Google made no mention of its plans for the power, its press release noted that clean energy is needed to reduce data center emissions.

Meeting a deadline set in President Trump’s May 23 executive order “Reforming Nuclear Reactor Testing at the Department of Energy,” the DOE on June 30 updated information on its National Environmental Policy Act (NEPA) rulemaking and implementation procedures and published on its website an interim final rule that rescinds existing regulations alongside new implementing procedures.

The Department of Energy’s Office of Nuclear Energy announced the recipients of “first call” 2025 Nuclear Science User Facilities (NSUF) Rapid Turnaround Experiment (RTE) awards on June 26. The 23 proposals selected from industry, national laboratories, and universities will receive a total of about $1.4 million. While each project is led by a different principal investigator, some call the same organization home. A total of 17 companies, labs, and universities are represented.

The World Bank and the International Atomic Energy Agency signed an agreement last week to cooperate on the construction and financing of advanced nuclear projects in developing countries, marking the first partnership since the bank ended its ban on funding for nuclear energy projects.

. . . and today.

Mosebey in 1984 . . .

I graduated from high school in 1969. My yearbook says my career ambition was to be a nuclear physicist. This was inspired by a paperback book I read: Men Who Made a New Physics by Barbara Lovett Cline. I enrolled as a physics student at Susquehanna University that fall and graduated four years later. Many job applications were sent out, but I quickly learned in any branch of physics you needed at least a master’s degree and preferably a Ph.D. So, I applied to the Penn State nuclear engineering program as a master’s degree candidate. This would not be nuclear physics, but it would be close enough. To help with expenses, Penn State had quite a few internships with branches of Westinghouse, and mine was a three-month-long stint that summer at the Liquid Metal Fast Breeder Reactor project at Waltz Mill, Pa. My job was to work on expanding the uranium-238 fast fission cross sections into the 20-MeV range. Of course, I had no idea what a cross section was, but my supervisor, Gene Paik, and my office partners, especially Colin Durston, were immensely helpful.

Texas Tech University and Fermi America shared plans on June 26 to build “the world’s largest advanced energy and artificial intelligence campus” in Amarillo, Texas, near the Pantex nuclear weapons plant. Fermi America is a company cofounded by former Texas governor and energy secretary Rick Perry and his son, Griffin Perry, a cofounder and past senior advisor at Grey Rock Investment Partners. The announcement—a first press release from relative newcomer Fermi America—says the company “proudly answers President Donald J. Trump’s call to deliver global energy and AI dominance.”

There is a critical knowledge gap regarding the health consequences of exposure to radiation received gradually over time. While there is a plethora of studies on the risks of adverse outcomes from both acute and high-dose exposures, including the landmark study of atomic bomb survivors, these are not characteristic of the chronic exposure to low-dose radiation encountered in occupational and public settings. In addition, smaller cohorts have limited numbers leading to reduced statistical power.

Orano Group subsidiary Orano Med, a developer of targeted alpha therapies for oncology, inaugurated the expansion of its main research and development center located in Plano, Texas. The facility is used in the development of radiopharmaceuticals and for conducting preclinical research focused on targeted alpha therapies using lead-212, an alpha-emitting radioisotope that has shown promise in treating various types of cancer.

The University of Missouri’s Board of Curators has created the NextGen MURR Working Group to serve as a strategic advisory body for the development of the NextGen MURR (University of Missouri Research Reactor).